Signe Sparre Beck-Nielsen
Overview
Explore the profile of Signe Sparre Beck-Nielsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
476
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Toftlund L, Beck-Nielsen S, Agertoft L, Halken S, Zachariassen G
Eur J Pediatr
. 2025 Mar;
184(3):224.
PMID: 40042625
No abstract available.
2.
Diaz-delCastillo M, Espersen R, Beck-Nielsen S, Rejnmark L, Heegaard A
J Clin Endocrinol Metab
. 2025 Feb;
PMID: 39969548
Objective: Hereditary hypophosphatemic disorders such as X-linked hypophosphatemia (XLH) are rare phosphate wasting disorders that cause abnormal bone mineralization, which manifests as bone deformities and dental problems. Pain, stiffness, and...
3.
Ali D, Carpenter T, Imel E, Ward L, Appelman-Dijkstra N, Chaussain C, et al.
J Clin Endocrinol Metab
. 2025 Feb;
PMID: 39960858
Background: An International Working Group (IWG) developed new guidelines on the diagnosis, evaluation, management, and monitoring of X-linked hypophosphatemia (XLH) in children. Over the past 5 years, important advances have...
4.
Seefried L, Aliberti F, Heier C, Arango-Sancho P, Biosse Duplan M, Sakka S, et al.
Orphanet J Rare Dis
. 2025 Feb;
19(Suppl 2):497.
PMID: 39901153
No abstract available.
5.
Toftlund L, Beck-Nielsen S, Agertoft L, Halken S, Zachariassen G
Eur J Pediatr
. 2025 Jan;
184(2):160.
PMID: 39883214
Conclusions: Fortified compared to non-fortified human milk post-discharge did not have an impact on BMD at 6 years of age in very preterm-born infants. Breastfed children demonstrated higher BMD than...
6.
Ali D, Mirza R, Alsarraf F, Hussein S, Abu Alrob H, Appelman-Dijkstra N, et al.
J Clin Endocrinol Metab
. 2024 Dec;
PMID: 39715351
Objective: To examine the highest certainty evidence addressing the management of X-linked hypophosphatemia (XLH) in adults to inform treatment recommendations. Methods: We searched Embase, MEDLINE, Web of Science, and Cochrane...
7.
Boot A, Ariceta G, Beck-Nielsen S, Brandi M, Briot K, Collantes C, et al.
Ther Adv Chronic Dis
. 2024 May;
15:20406223241247643.
PMID: 38764445
Background: X-linked hypophosphatemia (XLH) is a rare, progressive disorder characterized by excess fibroblast growth factor 23 (FGF23), causing renal phosphate-wasting and impaired active vitamin D synthesis. Burosumab is a recombinant...
8.
Herlin L, Herlin M, Blechingberg J, Ronholt K, Graversen L, Schmidt S, et al.
Eur J Med Genet
. 2024 Apr;
69:104937.
PMID: 38574886
Tricho-rhino-phalangeal syndrome (TRPS) is a rare malformation syndrome characterized by distinctive facial, ectodermal, and skeletal features. TRPS is divided into TRPS type I/III caused by pathogenic variants in TRPS1 and...
9.
Ariceta G, Beck-Nielsen S, Boot A, Brandi M, Briot K, Collantes C, et al.
Orphanet J Rare Dis
. 2023 Sep;
18(1):304.
PMID: 37752558
Background: X-linked hypophosphatemia (XLH) is a rare, hereditary, progressive, renal phosphate-wasting disorder characterized by a pathological increase in FGF23 concentration and activity. Due to its rarity, diagnosis may be delayed,...
10.
Beck-Nielsen S, Hasle H, Safwat A, Valancius K, Langdahl B, Hansen E
Bone Rep
. 2023 May;
18:101687.
PMID: 37250205
A giant cell tumour of bone presented in the os sacrum of a prepubertal girl. Surgery with reconstruction was performed, but total resection was impossible. Zoledronate failed to avoid tumour...